ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

Indian Journal of Neurosurgery, published by GEORG THIEME VERLAG KG, serves as a pivotal resource in the field of neurosurgery and clinical neurology. With an ISSN of 2277-954X and E-ISSN 2277-9167, this Open Access journal has made significant strides since its transition to an accessible format in 2012, ensuring that groundbreaking research is available to the global scientific community. The journal, situated in Stuttgart, Germany, aims to publish high-quality and innovative research, reviews, and discussions that address contemporary challenges in neurosurgery. Despite its recent ranking of 465/551 in Medicine (Surgery) and 361/400 in Medicine (Neurology - clinical), with percentiles of 15% and 9% respectively, the Indian Journal of Neurosurgery fosters a platform for emerging ideas that can propel advancements in neurosurgical practices. Researchers, professionals, and students are encouraged to contribute to and benefit from this dynamic publication, which continues to influence the evolution of neurosurgical knowledge and practices.

Clinical Orthopaedics and Related Research, published by Lippincott Williams & Wilkins, is a premier journal within the fields of orthopaedics and sports medicine, boasting a distinguished history since its inception in 1963. With an impressive impact factor and ranking within the top quartile (Q1) in multiple categories, including Medicine (miscellaneous), Orthopedics and Sports Medicine, Sports Science, and Surgery, this journal consistently delivers high-quality, peer-reviewed research that shapes contemporary practices and advancements in these critical areas. The journal is a vital resource for researchers, clinicians, and students, offering impactful studies and clinical trials that inform evidence-based practice and elevate the standards of patient care. With a strong commitment to the dissemination of innovative findings, Clinical Orthopaedics and Related Research serves as an essential platform for the exchange of ideas and discoveries that drive the future of orthopaedic health.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

BMJ Supportive & Palliative Care is a leading academic journal dedicated to advancing the field of supportive and palliative care, published by the esteemed BMJ PUBLISHING GROUP in the United Kingdom. With an ISSN of 2045-435X and an E-ISSN of 2045-4368, this journal showcases high-quality, peer-reviewed articles that cater to a diverse audience, including healthcare professionals, researchers, and students. Notably, it holds a commendable impact factor, reflecting its credibility and influence within the academic community. As of 2023, the journal ranks in the top quartile (Q1) for Medical and Surgical Nursing and holds prestigious positions in the Q2 category for Medicine (miscellaneous) and Oncology (nursing), demonstrating its significance in multiple disciplines. Research published in this journal aims to enhance patient-centered care practices and improve health outcomes, making it an invaluable resource for innovative studies and discussions in the field. With a commitment to open access principles, BMJ Supportive & Palliative Care serves as a pivotal platform for disseminating knowledge and supporting the ongoing professional development of its readership.

CURRENT PROBLEMS IN CANCER is an esteemed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of oncology and cancer research. With an ISSN of 0147-0272 and an E-ISSN of 1535-6345, it has been a vital resource for over four decades, converging years of expertise from 1976 to 2024. The journal is recognized for its impactful contribution to the field, currently holding a Q3 ranking in Cancer Research and a Q2 ranking in Oncology, reflecting its importance in disseminating significant advancements and discussions in the field. It is ranked #164 out of 404 in Medicine _ Oncology and #131 out of 230 in Biochemistry, Genetics and Molecular Biology _ Cancer Research on Scopus, indicating its relevance and reach among academic circles. Although it does not offer open access, the journal remains a crucial platform for researchers and professionals seeking to explore contemporary issues in cancer treatment and management. With its commitment to quality and innovation, CURRENT PROBLEMS IN CANCER serves as an essential conduit for knowledge sharing and research development in oncology and cancer science.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of oncology and cancer research, focusing on the latest advancements in clinical trials and therapeutic strategies for cancer management. With an ISSN of 0277-3732 and an E-ISSN of 1537-453X, this journal serves as an essential resource for the dissemination of high-quality research findings, scholarly reviews, and innovative methodologies, aiming to advance clinical oncology from 1982 to 2024. It is categorized in Q3 for Cancer Research and Q2 for Oncology, reflecting its significant role in the scientific community. In addition to its rigorous peer-reviewed content, the journal provides a platform for researchers and clinicians to share valuable insights, laying the groundwork for future breakthroughs in cancer treatment. Although it currently does not offer open-access options, the journal remains accessible to a wide audience through academic institutions and libraries. The AMERICAN JOURNAL OF CLINICAL ONCOLOGY is crucial for anyone involved in oncology research, making it a must-read for professionals dedicated to improving cancer care.

Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.